Skip to content

Comparison of characteristics of two drugs namely, CLONIDINE and FENTANYL as adjuncts to hyperbaric BUPIVACAINE, a drug commonly used for spinal anaesthesia in caesarean section

Comparison of block characteristics of intrathecal CLONIDINE and FENTANYL as adjuncts to hyperbaric BUPIVACAINE in lower segment caesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036556
Enrollment
66
Registered
2021-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium Health Condition 2: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: CLONIDINE: 0.5mcg/kg of CLONIDINE added to 0.06mg/cm of intrathecal BUPIVACAINE for group 2 patients undergoing caesarean section Control Intervention1: FENTANYL: 0.5mcg/kg of FENTANYL

Sponsors

nazareth hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with singleton pregnancy, belonging to ASA grade I and II 2. Patients posted for elective and emergency LSCS

Exclusion criteria

Exclusion criteria: 1.Patients with major neurological, cardiovascular, respiratory, renal, coagulation disorders 2.Patients with known hypersensitivity to local anaesthetics or study drugs. 3.Patients with local infection/spine deformity 4.Patients who refuse to give consent. 5.Patients whose height an weight cannot be measured before the surgery

Design outcomes

Primary

MeasureTime frame
To evaluate block characteristics of Intrathecal CLONIDINE versus FENTANYL as adjuncts to BUPIVACAINE in caesarean sectionTimepoint: 1 year

Secondary

MeasureTime frame
to compare the levels of sedation and associated side effects with the 2 test drugsTimepoint: 1 year

Countries

India

Contacts

Public ContactPooja Mary Sebastian

Nazareth Hospital

himjyotidas@rediffmail.com9862018017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026